Tag: Durvalumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Durvalumab

New Combination Drug for Endometrial Cancer Approved in EU - Medscape

Added to Collection on: 2024-08-14 19:45:33

Tags for this article:

Orphan drugs
Lung cancer
Antineoplastic drugs
Cancer immunotherapy
Durvalumab
Infectious causes of cancer
PARP inhibitor
Olaparib
Endometrial cancer
Non-small-cell lung cancer
PD-L1
Cancer
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi-Lynparza combo wins landmark EU nod for endometrial cancer

Added to Collection on: 2024-08-14 13:51:24

Tags for this article:

Orphan drugs
Antineoplastic drugs
Internet privacy
Tracking
Cancer immunotherapy
HTTP cookie
Durvalumab
Endometrial cancer
Pembrolizumab
PARP inhibitor
Cancer treatment
Olaparib

Click the tags to see associated articles and topics

View Article Details
ESMO 2024: Tecentriq/Avastin's prospects as the first HCC adjuvant therapy fade

Added to Collection on: 2024-09-15 15:21:28

Tags for this article:

Orphan drugs
Antineoplastic drugs
Infectious causes of cancer
Hepatology
Cancer immunotherapy
Atezolizumab
Pembrolizumab
Nivolumab
Hepatocellular carcinoma
Liver cancer
Durvalumab
Adjuvant therapy
Avastin

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Pharma gets CDSCO nod to import Durvalumab solutions - Business Standard

Added to Collection on: 2024-09-24 15:37:20

Tags for this article:

Durvalumab
AstraZeneca
ASTRAZENECA PHARMA INDIA

Click the tags to see associated articles and topics

View Article Details
AZ, Daiichi get FDA nod for Dato-DXd in breast cancer | pharmaphorum

Added to Collection on: 2025-01-19 02:36:53

Tags for this article:

Antineoplastic drugs
Orphan drugs
Immunology
Breast cancer
Lung cancer
Antibody-drug conjugate
Durvalumab
Trastuzumab deruxtecan
Non-small-cell lung cancer
HER2
Triple-negative breast cancer
Trastuzumab
AstraZeneca
Daiichi Sankyo

Click the tags to see associated articles and topics

View Article Details
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates

Added to Collection on: 2025-01-24 15:50:32

Tags for this article:

Orphan drugs
CYP3A4 inhibitors
Cystic fibrosis
Antineoplastic drugs
Durvalumab
Ivacaftor
Tezacaftor
Respiratory syncytial virus
ALK inhibitor
Non-small-cell lung cancer
Crizotinib
Anaplastic lymphoma kinase

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech doses first subject in Phase 2 study of Ampligen, Imfinzi | Markets Insider

Added to Collection on: 2025-02-25 14:54:28

Tags for this article:

Orphan drugs
Cancer immunotherapy
Rintatolimod
Durvalumab
Live attenuated influenza vaccine
AIM ImmunoTech
Checkpoint inhibitor
Ampligen
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech Advances Pancreatic Cancer Trial to Phase 2 with Ampligen-Imfinzi Combination

Added to Collection on: 2025-02-25 13:41:23

Tags for this article:

Orphan drugs
Durvalumab
Cancer immunotherapy
Checkpoint inhibitor
Rintatolimod
AstraZeneca
AIM ImmunoTech
PD-L1
Thomas K. Equels

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU - TipRanks.com

Added to Collection on: 2025-02-28 15:56:32

Tags for this article:

Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Daiichi Sankyo
Trastuzumab deruxtecan
AstraZeneca
HER2
Durvalumab
Trastuzumab
Breast cancer
Antibody-drug conjugate

Click the tags to see associated articles and topics

View Article Details
AstraZeneca, Daiichi Sankyo's Enhertu recommended for approval in EU | Markets Insider

Added to Collection on: 2025-02-28 14:37:34

Tags for this article:

Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Immunology
Daiichi Sankyo
Trastuzumab deruxtecan
HER2
AstraZeneca
Durvalumab
Trastuzumab
Breast cancer
Antibody-drug conjugate

Click the tags to see associated articles and topics

View Article Details